Department of Justice August 2019 – Federal Register Recent Federal Regulation Documents

Importer of Controlled Substances Registration
Document Number: 2019-18688
Type: Notice
Date: 2019-08-29
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-18687
Type: Notice
Date: 2019-08-29
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for ad been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-18686
Type: Notice
Date: 2019-08-29
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.
Importer of Controlled Substances Registration
Document Number: 2019-18685
Type: Notice
Date: 2019-08-29
Agency: Drug Enforcement Administration, Department of Justice
The registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as importers of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2019-18681
Type: Notice
Date: 2019-08-29
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities; Proposed Collection; Comments Requested; Request To Be Included on the List of Pro Bono Legal Service Providers for Individuals in Immigration Proceedings (Form EOIR-56)
Document Number: 2019-18566
Type: Notice
Date: 2019-08-28
Agency: Department of Justice
The Department of Justice (DOJ), Executive Office for Immigration Review, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Bulk Manufacturer of Controlled Substances Applications: Bulk Manufacturers of Marihuana
Document Number: 2019-18456
Type: Notice
Date: 2019-08-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is providing notice of certain applications it has received from entities applying to be registered to manufacture in bulk a basic class of controlled substances listed in schedule I. Prior to making decisions on these pending applications, DEA intends to promulgate regulations that govern the program of growing marihuana for scientific and medical research under DEA registration. In addition, this notice informs applicants that they may withdraw their applications if they no longer need to obtain a registration because of the recent amendments made by the Agriculture Improvement Act of 2018 to the definition of marihuana to no longer include ``hemp'' as defined by law.
Importer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2019-18455
Type: Notice
Date: 2019-08-27
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Nanosyn, Inc
Document Number: 2019-18454
Type: Notice
Date: 2019-08-27
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Akorn, Inc.
Document Number: 2019-18453
Type: Notice
Date: 2019-08-27
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration AMPAC Fine Chemicals Virginia, LLC
Document Number: 2019-18325
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
The registrant listed below have applied for and been granted a registration by the Drug Enforcement Administration (DEA) as a bulk manufacturer of various basic classes of schedule II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc.
Document Number: 2019-18324
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: AMRI Renesselaer, Inc.
Document Number: 2019-18323
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company
Document Number: 2019-18322
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cambrex High Point, Inc.
Document Number: 2019-18321
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Clinical Supplies Management Holdings, Inc.
Document Number: 2019-18320
Type: Notice
Date: 2019-08-26
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities; Proposed eCollection eComments Requested; Application To Transport Interstate or Temporarily Export Certain National Firearms Act (NFA) Firearms-ATF F 5320.20
Document Number: 2019-18275
Type: Notice
Date: 2019-08-26
Agency: Department of Justice, Bureau of Alcohol, Tobacco, Firearms and Explosives
The Department of Justice (DOJ), Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Organization of the Executive Office for Immigration Review
Document Number: 2019-18196
Type: Rule
Date: 2019-08-26
Agency: Executive Office for Immigration Review, Department of Justice
This interim rule amends the regulations related to the internal organization of the Executive Office for Immigration Review (``EOIR''). This interim rule reflects changes related to the establishment of an Office of Policy within EOIR in 2017, and makes related clarifications or changes to the organizational role of EOIR's Office of the General Counsel (``OGC'') and Office of Legal Access Programs (``OLAP''). This interim rule further updates the Department of Justice (``Department'') organizational regulations to synchronize them with EOIR's regulations, makes nomenclature changes to the titles of the members of the Board of Immigration Appeals (``BIA'' or ``Board''), and provides for a further delegation of authority from the Attorney General to the EOIR Director (``Director'') regarding the efficient disposition of appeals. This interim rule also clarifies the Director's authority to adjudicate cases following changes to EOIR's Recognition and Accreditation Program (``R&A Program'') in 2017.
Meeting of the Coordinating Council on Juvenile Justice and Delinquency Prevention
Document Number: 2019-18150
Type: Notice
Date: 2019-08-23
Agency: Department of Justice, Office of Justice Programs
The Coordinating Council on Juvenile Justice and Delinquency Prevention announces its next meeting.
Meeting of the Federal Advisory Committee on Juvenile Justice
Document Number: 2019-18149
Type: Notice
Date: 2019-08-23
Agency: Department of Justice, Office of Justice Programs
The Office of Juvenile Justice and Delinquency Prevention has scheduled a meeting of the Federal Advisory Committee on Juvenile Justice (FACJJ).
Paroling, Recommitting, and Supervising Federal Prisoners: Prisoners Serving Sentences Under the United States and District of Columbia Codes
Document Number: 2019-17239
Type: Rule
Date: 2019-08-22
Agency: Department of Justice, Parole Commission
The United States Parole Commission is amending its regulations and eliminating the term ``Executive Hearing Officer'' in order to allow for more clarity.
Schedules of Controlled Substances: Removal of 6β-naltrexol From Control
Document Number: 2019-17630
Type: Proposed Rule
Date: 2019-08-21
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to remove (5[alpha],6[beta])-17-(cyclopropylmethyl)-4,5-epoxymorphinan- 3,6,14- triol (6[beta]-naltrexol) and its salts from the schedules of the Controlled Substances Act (CSA). This scheduling action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. 6[beta]-Naltrexol is currently a schedule II controlled substance because it can be derived from opium alkaloids. This action would remove the regulatory controls and administrative, civil, and criminal sanctions applicable to controlled substances, including those specific to schedule II controlled substances, on persons who handle (manufacture, distribute, reverse distribute, dispense, conduct research, import, export, or conduct chemical analysis) or propose to handle 6[beta]-naltrexol.
Office on Violence Against Women; Notice of Request for Nominations for New Members for the Task Force on Research on Violence Against American Indian and Alaska Native Women
Document Number: 2019-17776
Type: Notice
Date: 2019-08-19
Agency: Department of Justice
The Office on Violence Against Women of the U.S. Department of Justice requests recommendations for individuals to serve as members on a federal advisory committee, the Task Force on Research on Violence Against American Indian and Alaska Native Women (Task Force). Recommendations should consist of a cover letter recommending the individual and explaining the individual's qualifications to serve on the Task Force, as well as a copy of the individual's resume or curriculum vitae. Self-recommendations are not accepted. If you would like to make a membership recommendation for this federal advisory committee, please send your recommendation to the email address or contact person listed below.
Agency Information Collection Activities; Proposed eCollection; eComments Requested; Return A-Monthly Return of Offenses Known to Police and Supplement to Return A-Monthly Return of Offenses Known to Police; Extension of a Currently Approved Collection
Document Number: 2019-17752
Type: Notice
Date: 2019-08-19
Agency: Department of Justice
Department of Justice (DOJ), Federal Bureau of Investigation (FBI), Criminal Justice Information Services (CJIS) Division will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at xx FR xxxx, on Month xx, xxxx allowing for a 60 day comment period.
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection
Document Number: 2019-17749
Type: Notice
Date: 2019-08-19
Agency: Federal Bureau of Investigation, Department of Justice
The Department of Justice, Federal Bureau of Investigation, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension, With Change, of a Currently Approved Collection: Prison Population Reports: Summary of Sentenced Population Movement-National Prisoner Statistics
Document Number: 2019-17748
Type: Notice
Date: 2019-08-19
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, Bureau of Justice Statistics, will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number
Document Number: 2019-17623
Type: Rule
Date: 2019-08-16
Agency: Drug Enforcement Administration, Department of Justice
Noroxymorphone is a derivative of opium and opiates and, as such, is a schedule II controlled substance. The Drug Enforcement Administration (DEA) has established the use of the Drug Enforcement Administration Code Number 9668 for tracking noroxymorphone and for establishing aggregate production quotas. This rule amends the Code of Federal Regulations (CFR) to reflect the current practice of using the Code Number 9668 for noroxymorphone. This rulemaking will list the schedule II controlled substance noroxymorphone as a basic class with the Code Number 9668. This rule does not affect the control of noroxymorphone as a schedule II controlled substance.
Brent E. Silvers, M.D.; Decision and Order
Document Number: 2019-17622
Type: Notice
Date: 2019-08-16
Agency: Drug Enforcement Administration, Department of Justice
Peter John Ulbrich, M.D.; Decision and Order
Document Number: 2019-17621
Type: Notice
Date: 2019-08-16
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities; Proposed eCollection eComments Requested; New Collection; Background Investigation Medical Release Forms
Document Number: 2019-17613
Type: Notice
Date: 2019-08-16
Agency: Federal Bureau of Investigation, Department of Justice
The Department of Justice, Federal Bureau of Investigation, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Privacy Act of 1974; Systems of Records
Document Number: 2019-17364
Type: Notice
Date: 2019-08-16
Agency: Department of Justice
Pursuant to the Privacy Act of 1974, and Office of Management and Budget (OMB) Circular No. A-108, notice is hereby given that the Executive Office for Immigration Review (EOIR), a component within the United States Department of Justice (DOJ or Department), proposes to develop a new system of records titled Office of the Chief Administrative Hearing Officer (OCAHO) Case Management System (CMS), JUSTICE/EOIR-002. The EOIR proposes to establish this system of records to track and manage case information and documents for OCAHO cases. The system provides an electronic platform to track cases and electronically maintain records previously maintained in paper form for the purpose of more efficiently managing these records and providing better access to the records for parties to the proceedings.
Privacy Act of 1974; Implementation
Document Number: 2019-17363
Type: Proposed Rule
Date: 2019-08-16
Agency: Department of Justice
In the Notices section of this issue of the Federal Register, the Executive Office for Immigration Review, (EOIR), a component within the United States Department of Justice (DOJ or Department), has published a notice of a new system of records: Office of the Chief Administrative Hearing Officer (OCAHO) Case Management System (CMS), JUSTICE/EOIR-002. In this notice of proposed rulemaking, the Department proposes for the reasons listed below to exempt this system of records from certain provisions of the Privacy Act in order to ensure the integrity of investigatory and adjudicatory records in cases before OCAHO. Public comment is invited.
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension With Change, of a Previously Approved Collection USMS Medical Forms
Document Number: 2019-17438
Type: Notice
Date: 2019-08-14
Agency: Department of Justice
The Department of Justice (DOJ), U.S. Marshals Service (USMS), will submit the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Sunshine Act Meeting
Document Number: 2019-17466
Type: Notice
Date: 2019-08-13
Agency: Foreign Claims Settlement Commission, Department of Justice
Advisory Board; Notice of Meeting
Document Number: 2019-17354
Type: Notice
Date: 2019-08-13
Agency: Department of Justice, National Institute of Corrections
Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection: OJP Standard Assurances
Document Number: 2019-17308
Type: Notice
Date: 2019-08-13
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection is published to obtain comments from the public and affected agencies.
Agency Information Collection Activities: Proposed New Information Collection Activity; Comment Request, Proposed Study Entitled “The National Baseline Study on Public Health, Wellness, & Safety”
Document Number: 2019-16597
Type: Notice
Date: 2019-08-12
Agency: Department of Justice
The Department of Justice (DOJ), Office of Justice Programs, National Institute of Justice, is submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.